⌘K

Home/Filings/4/0001104659-25-010550

4//SEC Filing

Birx Deborah 4

Accession 0001104659-25-010550

CIK 0000921114other

View on SEC.gov Company Profile

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:15 PM ET

Size

5.6 KB

Accession

0001104659-25-010550

Insider Transaction Report

Form 4

Period: 2025-02-05

Armata Pharmaceuticals, Inc.ARMP

DirectorChief Executive Officer

Transactions

Award
Stock Options (Right to Buy)
2025-02-05+240,000→ 240,000 total
Exercise: $2.04Exp: 2035-02-05→ Common Stock (240,000 underlying)

Footnotes (1)

[F1]Twenty-five percent (25%) of the Stock Options shall vest on February 5th of each of 2026, 2027, 2028, and 2029, in each case subject to continuous service through the applicable vesting date.

Documents

1 file

4
tm255864-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Armata Pharmaceuticals, Inc.

CIK 0000921114

Entity typeother

Related Parties

1

filerCIK 0001849673

Filing Metadata

Form type: 4
Filed: Feb 6, 7:00 PM ET
Accepted: Feb 7, 4:15 PM ET
Size: 5.6 KB

View on SEC.gov